NewslettersHuman Immunology News Favorable Immune Checkpoint Inhibitor Outcome of Patients with Melanoma and NSCLC Harboring FAT1 Mutations By Danielle Corrigan - June 24, 2022 0 The authors investigated the association of FAT atypical cadherin 1 (FAT1) mutations with immune checkpoint inhibitor response and outcome. [npj Precision Oncology] Full Article